Ensysce Biosciences, Inc. current report, 18 February 2021

SEC Filing Summary: Leisure Acquisition Corp. (8-K)

Business Context and Reporting Period

This Form 8-K was filed by Leisure Acquisition Corp. (LACQ) on February 18, 2021. The report discloses a material event involving Ensysce Biosciences, Inc., specifically the appointment of David Humphrey as Chief Financial Officer of Ensysce. This announcement was made jointly by Leisure and Ensysce in connection with a proposed business combination transaction.

Financial Metrics

The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for either Leisure Acquisition Corp. or Ensysce Biosciences, Inc. This report focuses solely on a corporate governance update and regulatory disclosure regarding the pending transaction.

Material Changes

The primary material change reported is the appointment of David Humphrey as the Chief Financial Officer of Ensysce Biosciences, Inc. No financial performance changes or comparative period data are included in this document.

Guidance, Outlook, and Risks

  • Transaction Status: Leisure intends to file a registration statement on Form S-4, which will include a proxy statement/prospectus regarding the proposed transaction with Ensysce.
  • Regulatory Disclosure: The information furnished in Item 7.01 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings.
  • Non-Solicitation: This communication is explicitly not a solicitation of proxies or an offer to sell securities. No sale of securities will occur until a prospectus meeting Securities Act requirements is available.
  • Participants: Directors and executive officers of both Leisure and Ensysce may be deemed participants in the solicitation of proxies for the proposed transaction.

Key Facts for Investor Verification

  • Verify the appointment of David Humphrey as Ensysce's CFO via the attached press release (Exhibit 99.1).
  • Monitor the upcoming filing of the Form S-4 registration statement for detailed terms of the proposed business combination.
  • Review the definitive proxy statement/prospectus once filed for comprehensive information on the transaction, risks, and management interests.
  • Confirm that no securities are being sold or solicited via this specific 8-K filing.